Pages that link to "Q33630577"
Jump to navigation
Jump to search
The following pages link to Therapeutic potential of nerve growth factors in Parkinson's disease (Q33630577):
Displayed 28 items.
- Cellular replacement therapy for Parkinson's disease--where we are today? (Q28206557) (← links)
- The primate model of Parkinson's disease: its usefulness, limitations, and importance in directing future studies (Q34120740) (← links)
- Neuroprotective effects of D3 dopamine receptor agonists (Q34237471) (← links)
- Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms (Q35025103) (← links)
- Intracranial delivery of proteins and peptides as a therapy for neurodegenerative diseases. (Q35607489) (← links)
- Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies. (Q35700596) (← links)
- Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model (Q35802100) (← links)
- Neuroprotection in Parkinson's disease: an elusive goal (Q35817235) (← links)
- GDNF delivery for Parkinson's disease. (Q36906842) (← links)
- Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats (Q37371366) (← links)
- Future of cell and gene therapies for Parkinson's disease (Q37696495) (← links)
- Enhanced Functional Recovery from Spinal Cord Injury in Aged Mice after Stem Cell Transplantation through HGF Induction. (Q37707502) (← links)
- Advances in non-dopaminergic treatments for Parkinson's disease (Q38218083) (← links)
- Trophic factors for Parkinson's disease: To live or let die. (Q38697393) (← links)
- Glial Cell Line-Derived Neurotrophic Factor Family Members Reduce Microglial Activation via Inhibiting p38MAPKs-Mediated Inflammatory Responses (Q39039257) (← links)
- Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex (Q39397445) (← links)
- Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons (Q39817440) (← links)
- Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease (Q39898054) (← links)
- Interactions of cyclic adenosine monophosphate, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor treatment on the survival and growth of postnatal mesencephalic dopamine neurons in vitro (Q40659852) (← links)
- Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. (Q40723341) (← links)
- High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine (Q41953160) (← links)
- Anti-Parkinson Activity of Petroleum Ether Extract of Ficus religiosa (L.) Leaves (Q41981198) (← links)
- Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease (Q42515795) (← links)
- Encapsulation of primary dopaminergic neurons in a GDNF-loaded collagen hydrogel increases their survival, re-innervation and function after intra-striatal transplantation (Q47137695) (← links)
- Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation (Q48181098) (← links)
- Gene Therapy for Parkinson's Disease, An Update. (Q55418920) (← links)
- Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis (Q59130137) (← links)
- BDNF in the Aged Brain: Translational Implications for Parkinson's Disease (Q94036987) (← links)